Kevin DeJong

ID: 1b83dfec-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

Tanvex Answers Genentech’s Trastuzumab Complaint

Big Molecule Watch · September 7, 2022

Samsung Bioepis and Organon Announce FDA Approval of Citrate-Free, High-Concentration Adalimumab Biosimilar

Big Molecule Watch · August 22, 2022

PTAB Institutes Sixth IPR on a Tocilizumab Patent Challenged by Fresenius

Big Molecule Watch · June 8, 2022

New BPCIA Complaint: Genentech Files Suit Against Tanvex Regarding its Proposed Herceptin Biosimilar

Big Molecule Watch · June 3, 2022

Amneal Achieves Third U.S. Biosimilar Approval with FYLNETRA (pegfilgrastim-pbbk)

Big Molecule Watch · May 27, 2022